Aphakia Versus Pseudophakia in Children Under 2 Years Undergoing Bilateral Congenital Cataract Surgery
NCT ID: NCT01297153
Last Updated: 2011-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
100 participants
INTERVENTIONAL
2003-05-31
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Trial : Complications of in the Bag IOL Versus Optic Capture of IOL in Pediatric Cataract Surgery
NCT02491918
Early Vs Late Post Traumatic Cataract Surgery
NCT02900365
Effect of the Timing of Cataract Surgery on Complications in Patients With Bilateral Congenital Cataracts
NCT02581046
Contrast Sensitivity Assessment in Pediatric Cataract Surgery With IOL Implantation
NCT01901744
Long-term Postoperative Outcomes After Bilateral Congenital Cataract Surgery in Eyes With Microphthalmos
NCT01818037
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Currently, there are 3 methods of optical rehabilitation following congenital cataract surgery :
1. Primary IOL implantation.
2. Aphakic glasses.
3. Contact lenses.
At present, there is no randomized clinical trial reported to document the safety and efficacy of IOL implantation in children less than 2 years.
Aim : To compare the technical outcome (safety) and functional outcome (benefits) following primary IOL implantation and aphakia in children less than 2 years.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aphakia
* The patient is randomly assigned for aphakia / pseudophakia. This is done only after vitrectomy. If it is aphakia,IOL will not be implanted.Aphakia will be corrected with aphakic glasses / contact lenses. Bilateral aphakes are given both contact lenses and glasses. So when they do not wear contact lenses they can put on aphakic glasses. Unilateral aphakes are given only contact lenses. Contact lenses should be fitted in the eye in OT immediately after the operation.
* Aphakic glasses :
Prescribed within 2 weeks of surgery for both eyes.
No IOL
No IOL will be implanted in these eyes
Pseudophakia
The patient is randomly assigned for aphakia / pseudophakia. This is done only after vitrectomy. Hydrophobic Acrysof IOL is implanted.All pseudophakic children will be refracted and given the residual correction within a month of surgery.
Intraocular Lens (Acrysof IOL)
IOL fixation, material and size are important determinants of immediate and long-term outcome. In-the-bag fixation is the most preferred site of IOL implantation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intraocular Lens (Acrysof IOL)
IOL fixation, material and size are important determinants of immediate and long-term outcome. In-the-bag fixation is the most preferred site of IOL implantation.
No IOL
No IOL will be implanted in these eyes
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Congenital cataract
* Bilateral cataracts
* IOL fixation - Bag/Ciliary fixated
Exclusion Criteria
* Microcornea (Horizontal corneal diameter \<9.5 mm-asper that particular age)
* Iris coloboma
* PHPV
* Aniridia
* \*Glaucoma - IOP more than or equal to 25 mmHg
* One eyed
* Cataract surgery already performed in fellow eye
24 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iladevi Cataract and IOL Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iladevi Cataract & IOL Research Centre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abhay R Vasavada, MS,FRCS
Role: PRINCIPAL_INVESTIGATOR
Iladevi Cataract And IOL Research Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Iladevi Cataract & IOL Research Centre
Ahmedabad, , India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
icircAP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.